205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.71%
Revenue growth similar to ADI's 7.37%. Walter Schloss would see if both companies share industry tailwinds.
1.74%
Gross profit growth under 50% of ADI's 8.03%. Michael Burry would be concerned about a severe competitive disadvantage.
-18.30%
Negative EBIT growth while ADI is at 19.77%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.30%
Negative operating income growth while ADI is at 19.77%. Joel Greenblatt would press for urgent turnaround measures.
3.42%
Net income growth under 50% of ADI's 18.86%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.42%
Share count expansion well above ADI's 0.31%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.42%
Diluted share count expanding well above ADI's 0.26%. Michael Burry would fear significant dilution to existing owners' stakes.
-3.31%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
92.86%
OCF growth above 1.5x ADI's 1.90%. David Dodd would confirm a clear edge in underlying cash generation.
237.50%
FCF growth above 1.5x ADI's 2.88%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-16.43%
Negative 10Y revenue/share CAGR while ADI stands at 115.68%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-2.34%
Negative 5Y CAGR while ADI stands at 29.41%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.48%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
23.60%
10Y OCF/share CAGR under 50% of ADI's 185.48%. Michael Burry would worry about a persistent underperformance in cash creation.
10.68%
5Y OCF/share CAGR at 75-90% of ADI's 12.47%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-41.48%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-18.75%
Negative 10Y net income/share CAGR while ADI is at 389.38%. Joel Greenblatt sees a major red flag in long-term profit erosion.
110.54%
5Y net income/share CAGR above 1.5x ADI's 26.53%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-90.75%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
285.08%
10Y equity/share CAGR at 50-75% of ADI's 437.22%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
66.14%
5Y equity/share CAGR at 50-75% of ADI's 120.28%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-14.43%
Negative 3Y equity/share growth while ADI is at 58.47%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
15.94%
Dividend/share CAGR of 15.94% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
1.45%
Dividend/share CAGR of 1.45% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
7.83%
3Y dividend/share CAGR of 7.83% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
5.49%
AR growth well above ADI's 4.90%. Michael Burry fears inflated revenue or higher default risk in the near future.
13.38%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.66%
Asset growth at 75-90% of ADI's 2.05%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
-1.39%
We have a declining book value while ADI shows 2.47%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-12.30%
We’re deleveraging while ADI stands at 0.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
3.92%
R&D growth drastically higher vs. ADI's 3.22%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.97%
SG&A growth well above ADI's 3.17%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.